Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2006
06/27/2006US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same
06/27/2006US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase
06/27/2006US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors
06/27/2006CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
06/22/2006WO2006066126A2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts
06/22/2006WO2006065277A2 Heterocyclic aspartyl protease inhibitors
06/22/2006WO2006065038A1 Method for preparation of organofluoro compounds in alcohol solvents
06/22/2006WO2006064945A1 Process for producing muscarine receptor antagonist and intermediate therefor
06/22/2006WO2006064039A1 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator
06/22/2006WO2006063656A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content
06/22/2006WO2006063654A1 Method for producing onium alkyl sulfates with a low halogenide content
06/22/2006WO2006063653A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content
06/22/2006WO2006063441A1 Compositions, redox couples and uses thereof
06/22/2006US20060135786 Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
06/22/2006US20060135620 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
06/22/2006US20060135587 Method and compounds for promoting healing and reducing inflammation
06/22/2006US20060135585 Compounds and methods for thiol-containing compound efflux and cancer treatment
06/22/2006US20060135584 Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same
06/22/2006US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile
06/22/2006US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents
06/22/2006US20060135559 Novel imidazoline compounds
06/22/2006US20060135556 Non-nucleoside reverse transcriptase inhibitors
06/22/2006US20060135513 Methods of treating tumors
06/22/2006CA2591033A1 Heterocyclic aspartyl protease inhibitors
06/22/2006CA2590780A1 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content
06/22/2006CA2590221A1 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator
06/22/2006CA2588575A1 Compositions, redox couples and uses thereof
06/21/2006EP1671955A1 Cationic symmetric imidazole diazocompounds with a non cationic linking group, compositions comprising them, dying process and kit thereof
06/21/2006EP1671954A1 Diazo compounds containing a 2-imidazolium group and their use in dyeing compositions
06/21/2006EP1670784A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
06/21/2006EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity
06/21/2006EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production
06/21/2006EP1146037B1 Process for the preparation of optically active amino alcohols
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006CN1791591A Bioreductively-activated prodrugs
06/21/2006CN1791572A Novel compounds
06/21/2006CN1791403A Compositions and methods for treating cancer
06/21/2006CN1789250A Optical antimer of a group of nitro imidazole derivatives, preparation method and uses thereof
06/20/2006US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064144 Imidazole derivatives as adenosine deaminase inhibitors
06/20/2006US7064142 Imidazonline compounds
06/20/2006CA2121523C Sulfonamide derivatives
06/15/2006WO2006062890A1 Method of making imidazole-2-thiones
06/15/2006WO2006061193A1 Indenyl derivatives and use thereof for the treatment of neurological disorders
06/15/2006US20060128996 Compositions containing Ionic liquids and uses thereof, especially in organic synthesis
06/15/2006US20060128903 Process for the controlled increase in the molecular weight of polyethylenes
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
06/15/2006US20060124893 Solvent extraction mixture for the separation of groups of base metals
06/15/2006US20060124017 New compounds, a process for their preparation and their use as dyes and pigments
06/15/2006US20060123565 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
06/15/2006CA2589831A1 Indenyl derivatives and use thereof for the treatment of neurological disorders
06/14/2006EP1669069A1 Compounds effecting glukokinase
06/14/2006EP1669068A1 Compounds effecting Glucokinase
06/14/2006EP1667984A1 Gamma-secretase inhibitors
06/14/2006CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient
06/14/2006CN1785975A Synthesis method of beta indolone
06/14/2006CN1259311C Process for preparing hydantoin by one-step method
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006US7060840 Using a chiral, non-racemic tertiary amine catalyst,e.g., one containing a 1-azabicyclo(2.2.2)octane moiety or a 1,4-diazabicyclo(2.2.2)octane moiety.
06/13/2006US7060806 Cationic azo dye compound
06/13/2006US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents
06/13/2006US7060110 Chromatic direct dyes
06/08/2006WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006WO2006058905A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY
06/08/2006WO2006058457A1 α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOL-1-ETHANOL DERIVATIVES
06/08/2006WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/08/2006US20060122400 Reacting vicinal diamine thiocarbonyl compound, then oxidizing intermediate; adrenergic receptor agonists/antagonists
06/08/2006US20060122398 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions
06/08/2006US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders
06/08/2006US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents
06/08/2006US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
06/08/2006US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate
06/08/2006US20060122100 Melanin extinguisher
06/08/2006US20060120991 N-halamine vinyl compounds and their polymeric biocides
06/08/2006CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006CA2588517A1 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
06/08/2006CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases
06/07/2006EP1666469A1 Plasminogen activator inhibitor-1 inhibitor
06/07/2006EP1666466A2 Mutilin derivatives and their use as Antimicrobials
06/07/2006EP1666458A1 Optically active 3,3 -dithiobis(2-amino-2-methylpropioni c acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methyl-propionic acid derivative
06/07/2006EP1664269A2 Alpha-keto carbonyl calpain inhibitors
06/07/2006EP1664088A2 Hemiasterlin derivatives and uses thereof
06/07/2006EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
06/07/2006EP1663960A2 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/07/2006EP1663953A1 Inhibitors of histone deacetylase
06/07/2006EP1663234A1 Piperazine derivatives for the treatment of hiv infections
06/07/2006EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
06/07/2006EP1663206A1 Nonsedating a-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione
06/07/2006EP1663105A2 Cycloalkyl heterocycles for treating hepatitis c virus
06/07/2006EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same
06/07/2006EP1048694B1 Azo compounds and process for producing the same
06/07/2006CN1784386A 1,2-diarylimidazoles useful as inhibitors of COX
06/07/2006CN1781914A Organic polymer and novel polymerizable compound
06/07/2006CN1781903A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/07/2006CN1258560C Hot curable epoxy composition in a separated container
06/06/2006US7057051 Substituted imidazoles as cannabinoid receptor modulators
06/06/2006US7057050 such as N-propyl-2-heptadecenyl imidazoline acrylate; for low carbon steel lines